Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of products for the treatment of Haemophilia A
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Bio Products Laboratory | 07343036 | - | 1 lot Plasma Derived Factor VIII | LOBBYIST Garnish Hall Enterprises Ltd (1 quarter) |
| Biotest (UK) Ltd | - | - | 1 lot Plasma Derived Factor VIII | - |
| Grifols UK Limited | 01456099 | - | 1 lot Plasma Derived Factor VIII | - |
| Novo Nordisk Ltd | 01118740 | - | 2 lots SHL rFVIII · EHL rFVIII | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Octapharma Ltd | 02372699 | - | 2 lots Plasma Derived Factor VIII · SHL rFVIII | - |
| Pfizer Ltd | 00526209 | - | 1 lot SHL rFVIII | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | - | 1 lot Emicizumab | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Shire Pharmaceuticals Limited | 02031674 | - | 2 lots SHL rFVIII · EHL rFVIII | - |
| Swedish Orphan Biovitrum Ltd | 04369760 | - | 1 lot EHL rFVIII | - |
This procurement was divided into 4 lots, each awarded separately. 13 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 4 Emicizumab | £3,100,000 initial term | 1 single bid — no competition | Roche Products Ltd | complete |
| Lot 2 SHL rFVIII | £22,813,000 initial term | 5 | Octapharma Ltd Novo Nordisk Ltd Pfizer Ltd Shire Pharmaceuticals Limited | complete |
| Lot 3 EHL rFVIII | £4,100,000 initial term | 3 | Novo Nordisk Ltd Shire Pharmaceuticals Limited Swedish Orphan Biovitrum Ltd | complete |
| Lot 1 Plasma Derived Factor VIII | £718,000 initial term | 4 | Grifols UK Limited Biotest (UK) Ltd Octapharma Ltd Bio Products Laboratory | complete |
Government spending data: These suppliers have received £386,239,650 in 3,213 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust and 16 more public bodies (2018-09-13 to 2026-03-31).